U.S. Markets closed

enVVeno Medical Corporation (5HJ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
4.3000+0.0400 (+0.94%)
At close: 08:01AM CEST

enVVeno Medical Corporation

70 Doppler
Irvine, CA 92618
United States
949 261 2900

IndustryMedical Devices
Full Time Employees24

Key Executives

NameTitlePayExercisedYear Born
Mr. Robert A. BermanCEO & Director665.65kN/A1963
Mr. Craig Thomas GlynnCFO, Treasurer & Sec.250.65kN/A1961
Dr. Marc H. Glickman M.D.Sr. VP & Chief Medical Officer456.95kN/A1949
Mr. Warren HancockCo-founderN/AN/AN/A
Dr. Hamed Alavi Ph.D.Sr. VP & Chief Technology OfficerN/AN/AN/A
Dr. Benedict Broennimann M.D.Chief Medical Officer of Outside of United StatesN/AN/A1957
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

Corporate Governance

enVVeno Medical Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.